1. Home
  2. PRPL vs ARMP Comparison

PRPL vs ARMP Comparison

Compare PRPL & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPL
  • ARMP
  • Stock Information
  • Founded
  • PRPL 2010
  • ARMP N/A
  • Country
  • PRPL United States
  • ARMP United States
  • Employees
  • PRPL N/A
  • ARMP N/A
  • Industry
  • PRPL Home Furnishings
  • ARMP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PRPL Consumer Discretionary
  • ARMP Health Care
  • Exchange
  • PRPL Nasdaq
  • ARMP Nasdaq
  • Market Cap
  • PRPL 125.6M
  • ARMP 104.3M
  • IPO Year
  • PRPL N/A
  • ARMP N/A
  • Fundamental
  • Price
  • PRPL $0.92
  • ARMP $3.14
  • Analyst Decision
  • PRPL Hold
  • ARMP Strong Buy
  • Analyst Count
  • PRPL 1
  • ARMP 1
  • Target Price
  • PRPL $1.00
  • ARMP $9.00
  • AVG Volume (30 Days)
  • PRPL 417.6K
  • ARMP 7.8K
  • Earning Date
  • PRPL 11-03-2025
  • ARMP 11-12-2025
  • Dividend Yield
  • PRPL N/A
  • ARMP N/A
  • EPS Growth
  • PRPL N/A
  • ARMP N/A
  • EPS
  • PRPL N/A
  • ARMP N/A
  • Revenue
  • PRPL $456,844,000.00
  • ARMP $6,868,000.00
  • Revenue This Year
  • PRPL N/A
  • ARMP $8.43
  • Revenue Next Year
  • PRPL $11.87
  • ARMP N/A
  • P/E Ratio
  • PRPL N/A
  • ARMP N/A
  • Revenue Growth
  • PRPL N/A
  • ARMP 84.67
  • 52 Week Low
  • PRPL $0.56
  • ARMP $0.90
  • 52 Week High
  • PRPL $1.29
  • ARMP $3.23
  • Technical
  • Relative Strength Index (RSI)
  • PRPL 42.72
  • ARMP 61.13
  • Support Level
  • PRPL $0.89
  • ARMP $3.08
  • Resistance Level
  • PRPL $0.99
  • ARMP $3.07
  • Average True Range (ATR)
  • PRPL 0.06
  • ARMP 0.08
  • MACD
  • PRPL -0.01
  • ARMP 0.00
  • Stochastic Oscillator
  • PRPL 12.80
  • ARMP 68.75

About PRPL Purple Innovation Inc.

Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms and other products. The Company has one reportable segment that operates an omni-channel distribution which allows the Company to offer a seamless shopping experience to its customers across multiple sales channels. It sells its products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

Share on Social Networks: